Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTβR-Reference-Cited by-同舟云学术

Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTβR

Published:2009-03 Issue:2 Volume:1 Page:128-141
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Michaelson Jennifer S.,Demarest Stephen J.,Miller Brian,Amatucci Aldo,Snyder William B.,Wu Xiufeng,Huang Flora,Phan Samantha,Gao Sharon,Doern Adam,Farrington Graham K.,Lugovskoy Alexey A.,Joseph Ingrid,Bailly Veronique,Wang Xin,Garber Ellen,Browning Jeff,Glaser Scott M.

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/mabs.1.2.7631

Reference39 articles.

1. Bispecific Antibodies: Molecules That Enable Novel Therapeutic Strategies

2. Engineering antibodies for clinical applications

3. Recombinant bispecific antibodies for cancer therapy

4. Recombinant approaches to IgG-like bispecific antibodies

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression and characterization of scFv-6009FV in Pichia pastoris with improved ability to neutralize the neurotoxin Cn2 from Centruroides noxius;International Journal of Biological Macromolecules;2024-08

2. Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancy;Nature Communications;2024-01-15

3. A bispecific antibody targeting HER2 and CLDN18.2 eliminates gastric cancer cells expressing dual antigens by enhancing the immune effector function;Investigational New Drugs;2024-01-10

4. Application of platform process development approaches to the manufacturing of Mabcalin™ bispecifics;Journal of Biotechnology;2023-11

5. Efficient production of bispecific antibody by FAST-Ig ^TM and its application to NXT007 for the treatment of hemophilia A;mAbs;2023-06-20